The Calmer Co International Ltd (ASX: CCO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

The Calmer Co International Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.28 million
P/E Ratio 6.70
Dividend Yield 0.00%
Shares Outstanding 1.38 billion
Earnings per share -0.008
Dividend per share N/A
Year To Date Return -14.29%
Earnings Yield 14.93%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • The Calmer Co International Ltd (ASX: CCO)
    Latest News

    rising asx share price represented by woman jumping in the air happily
    Share Market News

    The Fiji Kava (ASX:FIJ) share price rocketed 26% this morning. Here's why

    The Fiji Kava Ltd (ASX: FIJ) share price is rocketing today after the health and wellness company announced its products…

    Read more »

    share price rise
    Share Market News

    Fiji Kava share price explodes 71% after company lands partnership to supply to China

    The Fiji Kava share price flew higher today after the company announced a partnership allowing it to sell its products…

    Read more »

    Fiji Kava tablets sitting in a bowl
    Share Market News

    Fiji Kava share price soars 90% on Blackmores subsidiary agreement, trade paused

    The Fiji Kava share price soared nearly 90% following the signing of a major agreement with Blackmores-owned company BioCeuticals.

    Read more »

    CCO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About The Calmer Co International Ltd

    The Calmer Co International Ltd is mainly engaged in the research and development of selling kava extracts as a consumer product. Its business objective is the primary production of kava through a network of outsourced kava farms and via its Farm located in Fiji and the production and sale of kava supplements and complementary medicines. The company has produced three types of products in the market: shots, powders, and capsules. Its kava products have been sold in Australia, the USA, New Zealand, China, and Fiji.

    CCO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    24 May 2024 $0.01 $0.00 0.00% 31,180,780 $0.01 $0.01 $0.01
    23 May 2024 $0.01 $0.00 0.00% 400,000 $0.01 $0.01 $0.01
    22 May 2024 $0.01 $0.00 0.00% 299,000 $0.01 $0.01 $0.01
    21 May 2024 $0.01 $0.00 0.00% 99,041 $0.01 $0.01 $0.01
    20 May 2024 $0.01 $0.00 0.00% 455,573 $0.01 $0.01 $0.01
    17 May 2024 $0.01 $0.00 0.00% 6,628,751 $0.01 $0.01 $0.01
    16 May 2024 $0.01 $0.00 0.00% 13,025,678 $0.01 $0.01 $0.01
    15 May 2024 $0.01 $0.00 0.00% 22,205,200 $0.01 $0.01 $0.01
    14 May 2024 $0.01 $0.00 0.00% 14,393,751 $0.01 $0.01 $0.01
    13 May 2024 $0.01 $0.00 0.00% 6,888,340 $0.01 $0.01 $0.01
    10 May 2024 $0.01 $0.00 0.00% 19,370,016 $0.01 $0.01 $0.01
    09 May 2024 $0.01 $0.00 0.00% 9,250,000 $0.01 $0.01 $0.01
    08 May 2024 $0.01 $0.00 0.00% 2,412,626 $0.01 $0.01 $0.01
    07 May 2024 $0.01 $0.00 0.00% 23,229,081 $0.00 $0.01 $0.00
    06 May 2024 $0.00 $0.00 0.00% 173,629 $0.01 $0.01 $0.00
    03 May 2024 $0.01 $0.00 0.00% 214,561 $0.00 $0.01 $0.00
    02 May 2024 $0.01 $0.00 0.00% 3,552,945 $0.01 $0.01 $0.01
    01 May 2024 $0.01 $0.00 0.00% 115,778 $0.01 $0.01 $0.01
    30 Apr 2024 $0.01 $0.00 0.00% 9,783,086 $0.01 $0.01 $0.00
    29 Apr 2024 $0.01 $0.00 0.00% 8,614,383 $0.01 $0.01 $0.00
    26 Apr 2024 $0.00 $0.00 0.00% 750,000 $0.00 $0.00 $0.00

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    19 Mar 2024 Anthony Noble Sell 5,111,111 $22,999
    Off-market trade.
    19 Mar 2024 Anthony Noble Sell 744,608 $3,350
    Off-market trade.
    05 Dec 2023 James Tonkin Issued 4,111,111 $16,444
    Director remuneration.
    05 Dec 2023 Anthony Noble Issued 5,111,111 $20,444
    Director remuneration.
    05 Dec 2023 Anthony Noble Issued 5,111,111 $20,444
    Director remuneration.
    05 Dec 2023 Griffon Emose Issued 4,111,111 $16,444
    Director remuneration.
    05 Dec 2023 Zane Yoshida Issued 5,111,111 $20,444
    Director remuneration.
    02 Aug 2023 Anthony Noble Issued 748,530 $2,245
    Rights issue.
    02 Aug 2023 Anthony Noble Issued 748,530 $2,245
    Rights issue. 1,996,078 prior holding
    02 Aug 2023 Anthony Noble Issued 249,510 $998
    Rights issue.
    02 Aug 2023 Zane Yoshida Issued 956,250 $2,868
    Rights issue.
    02 Aug 2023 Zane Yoshida Issued 318,750 $1,275
    Rights issue.
    05 Jul 2023 Griffon Emose Issued 1,666,667 $5,000
    Director remuneration.
    01 Jun 2023 Zane Yoshida Buy 100,000 $300
    On-market trade.
    01 Jun 2023 Zane Yoshida Buy 1,000,000 $3,000
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Zane Yoshida Non-Executive Director Dec 2018
    Mr Yoshida was born and raised in the Fiji Islands. Professionally, he has been involved in various of start-ups in Australia, Asia and the United States. He is the Founder and Executive Director of The Calmer Co, producing a range of farm to shelf kava supplements and complementary medicines that are manufactured to HACCP/GMP standards and launched in various international markets under the FijiKava and TakiMai brand. These countries include Australia, New Zealand, USA and Fiji. He is a member of the Australian Institute of Company Directors and Vice President of the Australia Fiji Business Council.
    Mr James Dack Non-Executive DirectorNon-Executive Chairman Sep 2022
    Mr Dack began his career at St Vincent's Hospital, as a porter and after five years of hard work he was promoted to the position of payroll manager responsible for 2500 staff. He was approached by the Industrial relations division of the Department of Health to run the whole New South Wales public hospital payroll system. When James left the Department of Health, he became a founding partner of one of the most successful real estate companies in Australia. In 2014 he started Sunshine Group Investments where he is currently the Managing Director. He is on the Board of the Police and Citizens Youth Clubs New South Wales. James was awarded the Order of Australia Medal in the Kings Birthday honours for services to youth.
    Dr Anthony Noble Chief Executive OfficerManaging Director May 2021
    Dr Noble joined FijiKava. Prior to this he was CEO of Australian Biotherapeutics, a manufacturer of live biotherapeutics based in Coolum Beach, Queensland. Anthony worked at SFI Health and held roles as Managing Director of SFI Research Pty Ltd, as Global Head of Innovation, Group Head of North Asia and as General Manager of the SFI-Shineway Chinese Joint Venture. Anthony was Principal Scientist, for Cryosite Ltd and a lead inspector for the Human Tissue Authority (UK).
    Mr James S Tonkin Non-Executive Director Jan 2023
    Mr Tonkin is a retired Private Branding Agency owner. He has built and developed in market, many food and beverage brands mostly in the US marketplace. He was a entrepreneur as well as building and selling numerous businesses in his early career. Bringing more than 40 years in consulting and brand building experience in a range of household names globally gives James the ability to understand the strategies and marketability of products and service. James Tonkin has served on over 100 Boards in his long career.
    Mr Griffon Emose Non-Executive Director Jan 2023
    Mr Emose is the Managing Director of Kontiki Capital, a Fiji-based investment banking firm. He has experience in corporate finance and investment advisory, working in Fiji and the Pacific Islands. Prior to joining the Board, he was involved with CCO in an advisory capacity, overseeing the investment of Fiji institutional capital into CCO.
    Ms Natalie Sylvia Climo Company Secretary Jan 2024
    -
    Zane Yoshida Chief Operating Officer
    -
    Natalie Sylvia Climo Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Ace Property Holdings 38,000,000 4.31%
    James Dack 30,000,000 3.40%
    Mr Langley & Tarabay 29,166,667 3.31%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 27,456,310 3.11%
    Wayne Elsom 26,398,582 2.99%
    Ryan Gorman, Family & Gormco 22,651,319 2.57%
    Citicorp Nominees Pty Limited 20,453,998 2.32%
    Ian Leete, Family & Mial Enterprises 19,238,346 2.18%
    Bradfield Partners - Robert, Nicholas, Matt, Andrew & Ben Schulz 18,935,125 2.15%
    Zane Yoshida 17,902,933 2.03%
    Mr Fangtao Meng 15,679,008 1.78%
    Netwealth Investments Limited <Wrap Services A/C> 14,443,534 1.64%
    Netwealth Investments Limited<Super Services A/C> 13,816,776 1.57%
    Matthew Reede 10,494,444 1.19%
    Toffolo Nyc Pty Ltd<Toffolo Nyc S/F A/C> 10,000,000 1.13%
    Mr Tong Siong Tan 9,442,709 1.07%
    Sarantzouklis Family - Sarantzouklis Investments 9,375,000 1.06%
    Mr Stacey Hubert Carter 8,976,671 1.02%
    Cscde Pty Ltd <Bounds Green Super Fund A/C> 8,350,000 0.95%
    Edengreen Pty Ltd <The Ede Super Fund A/C> 8,000,000 0.91%
    Enster Pty Ltd <Rp Drummond Pl S/F A/C> 8,000,000 0.91%
    Bds Investments (Nsw) Pty Ltd <Bds S/F A/C> 8,000,000 0.91%
    Benchmark Fine Foods Pty Limited <Benchmark Super Fund A/C> 8,000,000 0.91%
    Pharmaceutical Sundries Pty Ltd <The Bennett Family S/F A/C> 8,000,000 0.91%
    Pj & Tk Watherston Pty Ltd <Petess Wathers S/F A/C> 8,000,000 0.91%
    Rarebit Pty Limited <Rarebit Super Fund A/C> 8,000,000 0.91%
    Vin Singh Pty Ltd <Dhanni Super Fund A/C> 8,000,000 0.91%

    Profile

    since

    Note